PL436978A1 - Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III) - Google Patents

Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Info

Publication number
PL436978A1
PL436978A1 PL436978A PL43697821A PL436978A1 PL 436978 A1 PL436978 A1 PL 436978A1 PL 436978 A PL436978 A PL 436978A PL 43697821 A PL43697821 A PL 43697821A PL 436978 A1 PL436978 A1 PL 436978A1
Authority
PL
Poland
Prior art keywords
sub
iii
water
complexes
soluble gold
Prior art date
Application number
PL436978A
Other languages
English (en)
Other versions
PL244960B1 (pl
Inventor
Stanisław Szczepaniak
Remigiusz SZCZEPANIAK
Dominika SZCZEPANIAK
Monika SZCZEPANIAK
Elwira SZCZEPANIAK
Original Assignee
Stanisław Szczepaniak
Szczepaniak Remigiusz
Szczepaniak Dominika
Szczepaniak Monika
Szczepaniak Elwira
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanisław Szczepaniak, Szczepaniak Remigiusz, Szczepaniak Dominika, Szczepaniak Monika, Szczepaniak Elwira filed Critical Stanisław Szczepaniak
Priority to PL436978A priority Critical patent/PL244960B1/pl
Priority to PCT/EP2022/053586 priority patent/WO2022171883A2/en
Publication of PL436978A1 publication Critical patent/PL436978A1/pl
Publication of PL244960B1 publication Critical patent/PL244960B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G7/00—Compounds of gold
    • C01G7/006—Compounds containing gold, with or without oxygen or hydrogen, and containing two or more other elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia są rozpuszczalne w wodzie kompleksy złota (III) przedstawione ogólnym wzorem. [Au(CN)<sub>m</sub>]<sub>n</sub><sup>(m-p)n</sup>(ClO<sub>2</sub>)<sub>rn</sub>, gdzie m ma wartość od 3 do 6, n ma wartość od 1 do 10, p ma wartość od 1 do 3, a r ma wartość od 0,1 do 2, do zastosowania jako samodzielny lek, albo wyrób medyczny, albo suplement diety, albo składnik środka farmaceutycznego w terapeutycznie uzasadnionej ilości i dowolnym sposobie podawania w stanach zapalnych.
PL436978A 2021-02-15 2021-02-15 Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III) PL244960B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL436978A PL244960B1 (pl) 2021-02-15 2021-02-15 Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)
PCT/EP2022/053586 WO2022171883A2 (en) 2021-02-15 2022-02-15 Water-soluble complexes of gold (iii) in medical uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL436978A PL244960B1 (pl) 2021-02-15 2021-02-15 Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Publications (2)

Publication Number Publication Date
PL436978A1 true PL436978A1 (pl) 2022-08-16
PL244960B1 PL244960B1 (pl) 2024-04-08

Family

ID=80625178

Family Applications (1)

Application Number Title Priority Date Filing Date
PL436978A PL244960B1 (pl) 2021-02-15 2021-02-15 Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Country Status (2)

Country Link
PL (1) PL244960B1 (pl)
WO (1) WO2022171883A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118593541B (zh) * 2024-08-07 2024-11-26 国科大杭州高等研究院 靶向NF-κB通路的手性金纳米材料在制备抗炎药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1276652A (en) 1968-06-07 1972-06-07 Newport Instr Ltd Improvements in or relating to gyromagnetic resonance apparatus
PL134859B1 (en) 1982-02-18 1985-09-30 Inst Spawalnictwa Nickel based brazing alloy
US4921847A (en) 1988-05-23 1990-05-01 Engelhard Corporation Trihalo(amine)gold(III) anti-tumor complexes
NL8901538A (nl) 1988-06-21 1990-01-16 Concord Research Corp Niet-metallische monoatomaire vormen van overgangselementen.
US5603963A (en) * 1994-07-28 1997-02-18 University Of Cincinnati Method for the treatment of retroviral diseases such as acquired immune deficiency syndrome utilizing (pseudo)halogen complexes of gold(1)
WO2000002882A1 (en) 1998-07-10 2000-01-20 Meiji Seika Kaisha Ltd. Novel x-ray intercepting metal complexes of chlorin derivatives
US7632827B2 (en) 2006-12-20 2009-12-15 The University Of Hong Kong Anti-cancer phosphine containing [AuIIIm(CNC)mL]n+ complexes and derivatives thereof and methods for treating cancer using such compositions
WO2010062846A1 (en) 2008-11-26 2010-06-03 Hammond Gerald B Synthesis of stable organogold compounds and methods of use thereof
WO2011158176A2 (en) 2010-06-17 2011-12-22 University Of Kwazulu-Natal Gold complexes
PL225149B1 (pl) * 2012-10-15 2017-02-28 Dominika Szczepaniak Rozpuszczalne w wodzie, stabilne kompleksy złota (III), sposób otrzymywania rozpuszczalnych w wodzie, stabilnych kompleksów złota (III) i ich zastosowanie
PL236093B1 (pl) * 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
CN111658758B (zh) 2020-05-27 2022-04-22 华南理工大学 一种抗菌金纳米簇及其制备方法与应用

Also Published As

Publication number Publication date
PL244960B1 (pl) 2024-04-08
WO2022171883A3 (en) 2022-10-13
WO2022171883A2 (en) 2022-08-18

Similar Documents

Publication Publication Date Title
ZA202305073B (en) Combination of antibody-drug conjugate and parp1 selective inhibitor
UA91512C2 (ru) Коньюгати олигомеров инсулина, их композиция (варианты) и применение
PT831825E (pt) Formulacoes farmaceuticas de derivados de camptotecina altamente lipofilos
JP6224165B2 (ja) 抗真菌医薬組成物
MX2024008000A (es) Combinacion de conjugado de anticuerpo-farmaco e inhibidor de cinasa relacionada con ataxia telangiectasia y rad3 (atr).
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
CA2692191C (en) Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
EA201101035A1 (ru) Новый конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем
MX2022016263A (es) Derivados de ciclobutil-urea.
MX2023005759A (es) Composiciones y metodos para suministro de farmaco dermico profundo.
JP5981419B2 (ja) 炎症性疾患の治療に使用するためのタマリンド種子多糖
PL436978A1 (pl) Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)
MX2020010201A (es) Conjugado de farmaco citotoxico y forma de profarmaco de dicho conjugado.
EA200501870A1 (ru) Новые производные имидазолов, способ их получения и их применение в качестве лекарственного средства
JP6779871B2 (ja) がん患者のための口腔ケア用組成物
MX2024006039A (es) Combinacion de conjugado de anticuerpo-farmaco e inhibidor selectivo de poli(adenosina-5&#39;-difosfato-ribosa) polimerasa 1 (parp1).
HUP9702443A2 (hu) Kondenzált terpénvázas Sarcodictyinszármazékokat tartalmazó tumorellenes hatású gyógyszerkészítmények
WO2008077772A3 (en) Combination of a retinoid and a platinum anticancer agent
EP1623741A2 (en) Cannabinoid receptor ligands for hair growth modulation
PL445382A1 (pl) Zastosowanie 8-glukozydu emodyny w leczeniu nowotworów układu nerwowego
NO20061515L (no) Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn
PL412005A1 (pl) Wodorozpuszczalne, inteligentne kompleksy złota (III) i zastosowanie wodorozpuszczalnych, inteligentnych kompleksów złota (III)
JP2007084496A (ja) 抗真菌剤組成物
AR054710A1 (es) Formulacion de proteinas mutadas de staphylococcal enterotoxina c1 (sec1) y metodo para su formulacion